Skip to main content
. 2021 Jul 7;13(7):1035. doi: 10.3390/pharmaceutics13071035

Figure 6.

Figure 6

Potential applications of altered gastric emptying time-, higher dose- or intestinal lumen concentration-, and slower drug release-associated changes in efflux transport kinetics. The altered efflux transport kinetics due to the aforementioned factors can be integrated in physiologically based pharmacokinetic (PBPK) modeling of orally absorbed efflux transporter substrate drugs.